Pharmaceutical Ingredients (for Research and Experimental Use)
COUNTRY OF ORIGIN
Japan
*USAGE / SAFETY STATEMENT
For laboratory research and development purposes only.
PURITY
>98.0%(T)(HPLC)
APPLICATION
Norlidocaine (monoethylglycinexylidide: MEGX): A Main Active Metabolite of Lidocaine
Norlidocaine (monoethylglycinexylidide: MEGX) is a main active metabolite of lidocaine [L0156] formed by oxidative N-deethylation catalyzed by CYP1A2 and CYP3A4 in the liver, and its formation depends on liver microsomal activity. Therefore, the dynamic liver function test based on the hepatic conversion of lidocaine to MEGX (called MEGX test) has been used as a tool for the real-time assessment of hepatic function. (The product is for research purpose only.)
Fukaya factory is certified for GMP, ISO14001:2004 (JQA-EM5386) and IQ Net (JP-JQA-EM5386).
PRECAUTIONARY STATEMENTS
P501 : Dispose of contents/ container to an approved waste disposal plant.
P270 : Do not eat, drink or smoke when using this product.
P264 : Wash skin thoroughly after handling.
P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth.
SUBCLASS
Pharmaceutical Ingredients (Others) (for Research and Experimental Use)
MDL ID
MFCD21334173
GHS PICTOGRAM CODES
GHS07
APPEARANCE
White to Almost white powder to crystal
PUBCHEM SUBSTANCE ID
468592497.0
SIGNAL WORD
Warning
HAZARD STATEMENTS
H302 : Harmful if swallowed.
BEILSTEIN/REAXYS NUMBER
3727115.0
HS NUMBER
2924.29.7790
PURITY / ANALYSIS METHOD
>98.0%(T)(HPLC)
PURITY (HPLC)
min. 98.0 area%
Questions & Answers (0)
Citations (0)
Shipping & Handling
Shipped In
Ambient
Safety & Storage
Storage Temperature
See product label for specific storage conditions.
Safety Statement
For laboratory research and development purposes only.
Regulatory & Compliance
We’re currently in BETA - Interested in joining? Let us know and we’ll get you set up with early access.
We’re currently in BETA - Interested in joining? Let us know and we’ll get you set up with early access.